Literature DB >> 28411832

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Robert S Stern1, Sherrie J Divito2.   

Abstract

Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made in understanding the causes and pathobiology of this often life-threatening condition. Su et al demonstrate associations between IL 15 serum levels and the outcome of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Their findings provide ideas for further investigations that may help us better understand the role of cytokines in this T-cell mediate disease and provides clues to possible new therapies.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28411832      PMCID: PMC5567821          DOI: 10.1016/j.jid.2017.01.003

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis.

Authors:  Sarah Guégan; Sylvie Bastuji-Garin; Ewa Poszepczynska-Guigné; Jean-Claude Roujeau; Jean Revuz
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

2.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Jui-Yung Yang; Shih-Chi Su; Shien-Ping Huang; Chun-Yu Wei; See-Wen Chin; Chien-Chun Chiou; Sung-Chao Chu; Hsin-Chun Ho; Chih-Hsun Yang; Chi-Fang Lu; Jer-Yuarn Wu; You-Di Liao; Yuan-Tsong Chen
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

3.  Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.

Authors:  Jean-Claude Roujeau; Sylvie Bastuji-Garin
Journal:  Ther Adv Drug Saf       Date:  2011-06

Review 4.  Interleukin 15: A key cytokine for immunotherapy.

Authors:  Manoj Patidar; Naveen Yadav; Sarat K Dalai
Journal:  Cytokine Growth Factor Rev       Date:  2016-06-07       Impact factor: 7.638

5.  Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.

Authors:  J Revuz; D Penso; J C Roujeau; J C Guillaume; C R Payne; J Wechsler; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

6.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

Authors:  I Garcia-Doval; L LeCleach; H Bocquet; X L Otero; J C Roujeau
Journal:  Arch Dermatol       Date:  2000-03

7.  Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.

Authors:  P Wolkenstein; J Latarjet; J C Roujeau; C Duguet; S Boudeau; L Vaillant; M Maignan; M H Schuhmacher; B Milpied; A Pilorget; H Bocquet; C Brun-Buisson; J Revuz
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

8.  The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

Authors:  J C Guillaume; J C Roujeau; J Revuz; D Penso; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

9.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

Review 10.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Authors:  Bana Jabri; Valérie Abadie
Journal:  Nat Rev Immunol       Date:  2015-11-16       Impact factor: 53.106

View more
  18 in total

1.  Early surgical correction of microstomia following Stevens-Johnson syndrome.

Authors:  Sae Hwi Ki; Gang Yeon Jo; Sung Hwan Ma; Matthew Seung Suk Choi
Journal:  Arch Craniofac Surg       Date:  2020-04-20

Review 2.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

Review 3.  An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

Authors:  Chun-Bing Chen; Riichiro Abe; Ren-You Pan; Chuang-Wei Wang; Shuen-Iu Hung; Yi-Giien Tsai; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2018-02-13       Impact factor: 4.818

4.  Incomplete Stevens-Johnson Syndrome Caused by Sulfonamide Antimicrobial Exposure.

Authors:  Nikki B Canter; Lane M Smith
Journal:  Clin Pract Cases Emerg Med       Date:  2019-05-29

Review 5.  Idiopathic toxic epidermal necrolysis in an adolescent.

Authors:  Kathleen F O'Brien; Rachel E Maiman; Kalyani Marathe
Journal:  Pediatr Dermatol       Date:  2019-03-31       Impact factor: 1.588

6.  Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure.

Authors:  Rannakoe J Lehloenya; Thuraya Isaacs; Tonderai Nyika; Ashar Dhana; Lauren Knight; Simon Veenstra; Jonny Peter
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-22

7.  A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Qin Xiang Ng; Michelle Lee Zhi Qing De Deyn; Nandini Venkatanarayanan; Collin Yih Xian Ho; Wee-Song Yeo
Journal:  J Inflamm Res       Date:  2018-03-28

Review 8.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

9.  Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review.

Authors:  Victoria López-Gómez; Ramón Yarza; Héctor Muñoz-González; Enrique Revilla; Santos Enrech; Olga González-Valle; Pablo Tolosa; Eva Ciruelos
Journal:  J Breast Cancer       Date:  2019-09-18       Impact factor: 3.588

Review 10.  Management of oral medicine emergencies during COVID-19: A study to develop practise guidelines.

Authors:  Na Lv; Ming Sun; Ajith Polonowita; Li Mei; Guangzhao Guan
Journal:  J Dent Sci       Date:  2020-08-07       Impact factor: 2.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.